Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
300677.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.01
vs 0.13
Q1.23
N/A
-0.23
vs 0.13
Q2.23
+40%
0.69
vs 0.49
Q3.23
-83%
0.06
vs 0.36
Q4.23
N/A
0.11
vs NA
Q1.24
+260%
0.36
vs -0.23
Q2.24
-21%
0.54
vs 0.69
Q3.24
+163%
0.16
vs 0.06
Q4.24
+1008%
1.21
vs 0.11
Q1.25
+53%
0.55
vs 0.36
Sales Growth
YoY
Current
Estimates
Q1.23
-39%
1.4B vs 2.3B
Q1.23
-31%
1.6B vs 2.3B
Q2.23
+19%
1.7B vs 1.5B
Q3.23
+19%
1.7B vs 1.5B
Q4.23
NA
1.9B vs NA
Q1.24
+39%
2.2B vs 1.6B
Q2.24
+33%
2.3B vs 1.7B
Q3.24
+48%
2.6B vs 1.7B
Q4.24
+29%
2.4B vs 1.9B
Q1.25
+13%
2.5B vs 2.2B
Return on Equity
QoQ
Q2.23
+3%
0.03
vs -0.01
Q3.23
+0%
0
vs 0.03
Q4.23
+0%
0
vs 0
Q1.24
+1%
0.01
vs 0
Q2.24
+2%
0.02
vs 0.01
Q3.24
+1%
0.01
vs 0.02
Q4.24
+4%
0.04
vs 0.01
Q1.25
+2%
0.02
vs 0.04
Institutionnal Ownership
Quote Panel
Key Metrics
Intco Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical disposable products and durable medical equipment in China and internationally. The company offers gloves; face masks and shields; ECG electrode; apparels, such as isolation gowns; hand sanitizer gel and spray; grounding pads; electrosurgical pencil; ESU cable and tip cleaner; and tens electrode. It also provides wheelchairs, scooters, and other medical equipment; hot and cold products, emergency treatment products, and mother and baby products; and home care products. The company was formerly known as Intco Medical Technology Co., Ltd. and changed its name to Intco Medical Technology Co., Ltd. in January 2020. Intco Medical Technology Co., Ltd. was founded in 2009 and is based in Zibo, China.
SHZ
-0.10Â ( -0.37%)
Relative Strenght
Volume Buzz
64%
Earning Acce
No
Dist 52w H.
20%Relative Strength
300677.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
424%2026-Revenue
436%2026-EPS
866%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 300677.SZ compares to sector?